Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.
Vertex Pharmaceuticals (VRTX) Gets a Hold from RBC Capital
In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), ...
Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
This was the stock's second consecutive day of losses.
bovnews4d
Why Did Barclays Give Vertex Pharmaceuticals Incorporated (VRTX) Stock Equal Weight Rating?
Barclays has recently reduced Vertex Pharmaceuticals Incorporated (VRTX) stock to Equal Weight rating, as announced on August 5, 2024, according to Finviz. Earlier, on June 27, 2024, Redburn Atlantic ...
Evercore ISI Sticks to Its Buy Rating for Aura Biosciences Inc (AURA)
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Aura Biosciences Inc (AURA – Research Report) on September 13 and set a price ...